Specific immunotherapy for latex allergy

3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the efficacy of subcutaneous and sublingual immunotherapy for type I latex allergy in reducing allergen sensitivity following latex exposure. To evaluate the safety of subcutaneous and sublingual immunotherapy for type I latex allergy.

Cite

CITATION STYLE

APA

Makatsori, M., Durham, S., & Calderon, M. A. (2017, April 28). Specific immunotherapy for latex allergy. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD009240.pub2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free